What it is

A cutting-edge blood test that detects circulating tumor cells (CTCs) that may have detached from a primary tumor or early-stage metastasis.

Why we do it

CTCs are responsible for cancer progression and recurrence. Detecting these cells early provides critical insight into your cancer risk and the effectiveness of ongoing treatments.

Overview

A simple blood sample allows us to measure the total number of circulating tumor cells. Tracking these levels over time helps monitor disease activity and evaluate treatment response, allowing for timely interventions.